Hovione, which offers a wide range of inhalation drug development and manufacturing services, has announced that it will add 30,600 sq ft and a new commercial spray dryer to its East Windsor, NJ facility.
The expansion will more than double the plant’s size and capacity, and the company said that it expects to hire approximately 60 new employees to support the added capacity. The expanded facility, which will have the ability to handle potent APIs, is expected to be fully operational early in 2017.
In July 2015, the company announced that it was adding spray drying capacity at its Loures, Portugal site and expects that project to be complete by March 2016.
Hovione New Jersey General Manager Marco Gil commented, “Expanding our manufacturing presence in USA highlights our commitment to our customers that want to manufacture their products in the US and to support the development needs of our ever expanding local customer base. The additional capacity will give us more flexibility and make us more agile to deal with our customer’s fast paced projects.”
Read the Hovione press release.
